Clinical Trials Browser

Phase 2 × INDUSTRY × NVP-BKM120 × Clear all

NCT02159066 2024-03-05

LOGIC-2

Phase 2 Completed

158 enrolled 40 charts

Melanoma

NCT02000882 2022-02-07

STAR Cape+BKM120 MBC With Brain Met

Phase 2 Completed

10 enrolled 11 charts

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01816594 2019-11-14

NeoPHOEBE

Phase 2 Completed

50 enrolled 23 charts

Breast Neoplasms

NCT01289041 2019-05-30

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Phase 2 Completed

70 enrolled 8 charts

Advanced Endometrial Cancer

NCT01833169 2018-10-19

SIGNATURE

Phase 2 Completed

146 enrolled 17 charts

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT01923168 2018-09-14

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Phase 2 Completed

340 enrolled 39 charts

Breast Neoplasms

NCT01852292 2018-07-24

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

Phase 2 Terminated

157 enrolled 22 charts

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT01297491 2016-03-11

BASALT-1

Phase 2 Completed

63 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung